Grehan S - Search Results

1

Expression of the apolipoprotein E gene in the skin is controlled by a unique downstream enhancer.

Grehan S, Allan C, Tse E, Walker D, Taylor JM. Grehan S, et al. J Invest Dermatol. 2001 Jan;116(1):77-84. doi: 10.1046/j.1523-1747.2001.00213.x. J Invest Dermatol. 2001. PMID: 11168801 Free article.

2

Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue.

Shih SJ, Allan C, Grehan S, Tse E, Moran C, Taylor JM. Shih SJ, et al. Among authors: grehan s. J Biol Chem. 2000 Oct 13;275(41):31567-72. doi: 10.1074/jbc.M005468200. J Biol Chem. 2000. PMID: 10893248 Free article.

3

Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain.

Grehan S, Tse E, Taylor JM. Grehan S, et al. J Neurosci. 2001 Feb 1;21(3):812-22. doi: 10.1523/JNEUROSCI.21-03-00812.2001. J Neurosci. 2001. PMID: 11157067 Free PMC article.

4

Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.

Kane D, Jensen LE, Grehan S, Whitehead AS, Bresnihan B, Fitzgerald O. Kane D, et al. Among authors: grehan s. J Rheumatol. 2004 Jul;31(7):1274-80. J Rheumatol. 2004. PMID: 15229943

5

Serum amyloid A in the assessment of early inflammatory arthritis.

Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O. Cunnane G, et al. Among authors: grehan s. J Rheumatol. 2000 Jan;27(1):58-63. J Rheumatol. 2000. PMID: 10648018 Clinical Trial.

6

Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.

Grehan S, Herbert J, Whitehead AS. Grehan S, et al. Eur J Immunol. 1997 Oct;27(10):2593-9. doi: 10.1002/eji.1830271019. Eur J Immunol. 1997. PMID: 9368615

7

Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6.

Uhlar CM, Grehan S, Steel DM, Steinkasserer A, Whitehead AS. Uhlar CM, et al. Among authors: grehan s. J Immunol Methods. 1997 Apr 25;203(2):123-30. doi: 10.1016/s0022-1759(96)00220-7. J Immunol Methods. 1997. PMID: 9149805

8

Expression of a biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response.

Grehan S, Uhlar CM, Sim RB, Herbert J, Whitehead AS. Grehan S, et al. J Immunol. 1997 Jul 1;159(1):369-78. J Immunol. 1997. PMID: 9200475

9

Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.

Muhlestein JB, Grehan S. Muhlestein JB, et al. Among authors: grehan s. Drugs R D. 2013 Sep;13(3):207-13. doi: 10.1007/s40268-013-0026-4. Drugs R D. 2013. PMID: 23990357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters